Piramal Pharma Q2 Results; stock zooms 13%

Posted by on



PAT soars 350% YoY to Rs 23 cr
Revenue from Operations grew by 17% YoY to Rs 2,242 cr
EBITDA grew by 28% YoY to Rs 403 cr

Comments

Post a Comment